Improving myocardial perfusion by percutaneous coronary intervention reduces central sympathetic activity in stable angina

Clinical Cardiology

Volumn 33, Issue 6, 2010, Pages

  Gomes, Marc E ^a   Aengevaeren, Wim R ^a   Lenders, Jacques W ^a   Verheugt, Freek W ^a   Smits, Paul ^a   Tack, Cees J ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CATECHOLAMINE; NORADRENALIN; BIOLOGICAL MARKER;

ADULT; AGED; ARTICLE; CARDIOVASCULAR SYMPTOM; CATECHOLAMINE BLOOD LEVEL; CLINICAL ARTICLE; FEMALE; HEART MUSCLE PERFUSION; HEART MUSCLE REVASCULARIZATION; HEART RATE VARIABILITY; HUMAN; MALE; MUSCLE CONTRACTION; MUSCLE SYMPATHETIC NERVE ACTIVITY; NERVE CONDUCTION; NORADRENALIN BLOOD LEVEL; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; STABLE ANGINA PECTORIS; SYMPATHETIC TONE; ADRENERGIC SYSTEM; ANGINA PECTORIS; BLOOD; COMPLICATION; CORONARY ARTERY BLOOD FLOW; ELECTROCARDIOGRAPHY; ELECTROSTIMULATION; HEART RATE; INNERVATION; METABOLISM; MIDDLE AGED; MYOCARDIAL ISCHEMIA; NETHERLANDS; PATHOPHYSIOLOGY; SEVERITY OF ILLNESS INDEX; SKELETAL MUSCLE; TIME; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME;

AGED; ANGINA PECTORIS; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; BIOLOGICAL MARKERS; CORONARY CIRCULATION; ELECTRIC STIMULATION; ELECTROCARDIOGRAPHY; FEMALE; HEART RATE; HUMANS; MALE; MIDDLE AGED; MUSCLE, SKELETAL; MYOCARDIAL ISCHEMIA; NETHERLANDS; NOREPINEPHRINE; SEVERITY OF ILLNESS INDEX; SYMPATHETIC NERVOUS SYSTEM; TIME FACTORS; TREATMENT OUTCOME; ANGIOPLASTY, BALLOON, CORONARY;

EID: 77953825000     PISSN: 01609289     EISSN: 19328737     Source Type: Journal    
DOI: 10.1002/clc.20676     Document Type: Article

References (20)

1. Graham LN, Smith PA, Stoker JB, Mackintosh AF, Mary DASG. Time course of sympathetic neural hyperactivity after uncomplicated acute myocardial infarction. Circulation. 2002;106(7):793-797.
2. Graham LN, Smith PA, Stoker JB, Mackintosh AF, Mary DA. Sympathetic neural hyperactivity and its normalisation following unstable angina and acute myocardial infarction. Clin Sci (Lond). 2004;106:567-568.
3. Minisi AJ, Thames MD. Activation of cardiac sympathetic afferents during coronary occlusion. Evidence for reflex activation of sympathetic nervous system during transmural myocardial ischemia in the dog. Circulation. 1991;84(1):357-367.
4. Thames MD, Kinugawa T, Dibner-Dunlap ME. Reflex sympathoexcitation by cardiac sympathetic afferents during myocardial ischemia. Role of adenosine. Circulation. 1993;87(5):1698-1704.
5. Longhurst JC, Tjen AL, Fu LW. Cardiac sympathetic afferent activation provoked by myocardial ischemia and reperfusion - Mechanisms and reflexes. In Neuro-Cardiovascular Regulation: from Molecules to Man, p74, (Ed. Chapleau MW. Irvine, California: New York academic sciences publishers) 2001.
6. Mccance AJ, Forfar JC. Selective enhancement of the cardiac sympathetic response to exercise by anginal chest pain in humans. Circulation. 1989;80(6):1642-1651.
7. Delius W, Hagbarth KE, Hongell A, Wallin BG. General characteristics of sympathetic activity in human muscle nerves. Acta Physiol Scand. 1972;84(1):65-81.
8. Mano T, Iwase S, Toma S. Microneurography as a tool in clinical neurophysiology to investigate peripheral neural traffic in humans. Clin Neurophysiol. 2006;117(11):2357-2384. (Pubitemid 44548487)
9. Grassi G, Seravalle G, Dell'Oro R, et al. Comparative effects of candesartan and hydrochlorothiazide on blood pressure, insulin sensitivity, and sympathetic drive in obese hypertensive individuals: results of the CROSS study. J Hypertens. 2003;21(9):1761-1769. (Pubitemid 37076361)
10. Grassi G, Seravalle G, Cattaneo BM, et al. Sympathetic activation and loss of reflex sympathetic control in mild congestive heart failure. Circulation. 1995;92(11):3206-3211. (Pubitemid 26360535)
11. Grassi G, Esler M. How to assess sympathetic activity in humans. J Hypertens. 1999;17(6):719-734. (Pubitemid 29322156)
12. Mary DA, Stoker JB. The activity of single vasoconstrictor nerve units in hypertension. Acta Physiol Scand. 2003;177(3):367-376.
13. Willemsen JJ, Ross HA, Jacobs MC, et al. Highly sensitive and specific HPLC with fluorometric detection for determination of plasma epinephrine and norepinephrine applied to kinetic studies in humans. Clin Chem. 1995;41(10):1455-1460.
14. Yucha CB. Use of microneurography to evaluate sympathetic activity in hypertension: a brief review. Appl Psychophysiol Biofeedback. 2000;25(1):55-63.
15. Remme WJ. The sympathetic nervous system and ischaemic heart disease. Eur Heart J. 1998;19(suppl F):F62-F71. (Pubitemid 28266411)
16. Abe M, Iwaoka M, Nakamura T, et al. Association of high levels of plasma free dopamine with future coronary events in patients with coronary artery disease. Circ J. 2007;71(5):688-692.
17. Mann DL, Kent RL, Parsons B, Cooper G. Adrenergic effects on the biology of the adult mammalian cardiocyte. Circulation. 1992;85(2):790-804.
18. Nikolaidis LA, Poornima I, Parikh P, Magovern M, Shen YT, Shannon RP. The effects of combined versus selective adrenergic blockade on left ventricular and systemic hemodynamics, myocardial substrate preference, and regional perfusion in conscious dogs with dilated cardiomyopathy. J Am Coll Cardiol. 2006;47(9):1871-1881.
19. Poole-Wilson PA, Swedberg K, Cleland JG, et al. Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the carvedilol or metoprolol european trial (COMET): randomised controlled trial. Lancet. 2003;362(9377):7-13.
20. Esler M, Jennings G, Lambert G, Meredith I, Horne M, Eisenhofer G. Overflow of catecholamine neurotransmitters to the circulation: source, fate, and functions. Physiol Rev. 1990;70(4):963-985.